PubRank

Joseph P Dougherty

Author PubWeight™ 21.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol 2002 2.50
2 A newly discovered function for RNase L in regulating translation termination. Nat Struct Mol Biol 2005 1.80
3 Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma. AIDS Res Hum Retroviruses 2009 1.66
4 Global analysis of Pub1p targets reveals a coordinate control of gene expression through modulation of binding and stability. Mol Cell Biol 2005 1.50
5 The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy. J Virol 2004 1.27
6 Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem 2002 1.09
7 High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J Virol 2006 1.08
8 Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors. Hepatology 2003 1.00
9 Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Ther 2012 1.00
10 High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor. J Biol Chem 2011 0.97
11 Human immunodeficiency virus type 1 latency model for high-throughput screening. Antimicrob Agents Chemother 2005 0.94
12 Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen. Blood 2004 0.88
13 Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1. Antimicrob Agents Chemother 2003 0.83
14 A HIV-2-based self-inactivating vector for enhanced gene transduction. J Biotechnol 2006 0.83
15 Post-transcriptionally regulated expression system in human xenogeneic transplantation models. Mol Ther 2011 0.78
16 Choice and use of appropriate packaging cell types. Methods Mol Biol 2003 0.77
17 HIV type-1 latency: targeted induction of proviral reservoirs. Antivir Chem Chemother 2009 0.77
18 Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2. J Virol 2006 0.77
19 Host stem cells can selectively reconstitute missing lymphoid lineages in irradiation bone marrow chimeras. Blood 2003 0.77
20 Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency. Autoimmunity 2010 0.75